|
Catalogue
Number
|
Product
|
Order number / Unit
|
|
|
7000
|
MIBG Hemisulfate
|
7000.0002: 2 mg per vial
7000.0005: 5 mg per vial
7000.0025: 25 mg per vial
7000.0050: 50 mg per vial
7000.0100: 100 mg per vial
7000.1000: 1 g per vial
Please inquire for customized
filling and bulk quantities.
|
|
|
Precursor for [*I]Metaiodobenzylguanidine
|
|
|
|
|
|
|
|
|
Molar Mass: 324.13
|
|
|
C8H10IN3 ⋅ 1/2 H2SO4
|
|
|
[87862-25-7]
[80663-95-2] (free base)
|
|
|
|
|
|
White to off-white solid packaged in dark glass crimp cap vials (7000.0002 and 7000.0005) or screw cap vials (7000.0025, 7000.0050, 7000.0100, and 7000.1000)
|
|
|
|
|
|
|
|
|
Purity: > 99 % (HPLC)
|
|
|
Certificates:
CoA; 1H NMR spectrum; HPLC
|
|
|
Chemical Name:
CA index name: Guanidine, [(3-iodophenyl)methyl]-, sulfate (2:1)
|
|
|
Synonymes:
(3-Iodobenzyl)guanidine hemisulfate; meta-Iodobenzylguanidine hemisulfate; Iobenguane sulfate
|
|
|
Literature:
Wieland D.M. et al. Imaging the primate adrenal medulla with [123I] and [131I]metaiodobenzylguanidine: concise communication. J. Nucl. Med. 1981, 22, 358-364.
|
|
|
Shapiro B. et al. Iodine-131 Metaiodobenzylguanidine for the locating of suspected pheochromocytoma; experience on 400 cases. J. Nucl. Med. 1985, 26, 576-585.
|
|
|
Moll V.O.N. et al. Iodine-131 MIBG scintigraphy of neuroend-ocrine tumors other than pheocharomycotoma and neuroblasterna. J. Nucl. Med. 1987, 28, 979-988.
|
|
|
|
|
|
|
|
|
date of product catalogue issue:
10 May 2017
|